Zealand Pharma Seeks Partners for Rare-disease Assets as Obesity Focus Grows
Summary
Danish biotech Zealand Pharma has resumed talks with potential partners for rare-disease drug glepaglutide as it focuses investment on its obesity pipeline, the company's... Reuters Health Information
Description from Medscape.
Who is covering this
-
Zealand Pharma Seeks Partners for Rare-disease Assets as Obesity Focus Grows
Danish biotech Zealand Pharma has resumed talks with potential partners for rare-disease drug glepaglutide as it focuses investment on its obesity pipeline, the company's... Reuters Health Information
Related stories
Albertsons must pay $900 million for fueling opioid epidemic in Washington state, judge rules
2 sourcesvia ReutersTruth score 52
Lilly to sell obesity drugs directly on Hims & Hers site
3 sourcesvia ReutersTruth score 63
Tens of thousands of tents flooded after heavy rains in Gaza
18 sourcesvia BBC NewsTruth score 8718
Justice Department Intervenes in Planned Parenthood Lawsuit in Texas
5 sourcesvia The New York TimesTruth score 75
Yemen war: Pregnant women struggle to access life-saving healthcare
3 sourcesvia Al Jazeera EnglishTruth score 571
My mother told me I would die if I sought treatment for Ebola - I am proof you can survive
16 sourcesvia BBC NewsTruth score 891
Comments
Comments need JavaScript.